105 related articles for article (PubMed ID: 31748012)
1. Intercellular Crosstalk of Mesenchymal Stem Cells with Prostate Cancer Cells via Microvesicles Loaded with Magnetic Nanocubes for Targeted Magnetic Hyperthermia.
Huang L; Chen M; Xu C; Feng Q; Wu J; Gao L; Xu P; Ning P; Wen X; Cheng Y
J Biomed Nanotechnol; 2019 Dec; 15(12):2291-2304. PubMed ID: 31748012
[TBL] [Abstract][Full Text] [Related]
2. Intelligent Photosensitive Mesenchymal Stem Cells and Cell-Derived Microvesicles for Photothermal Therapy of Prostate Cancer.
Huang L; Xu C; Xu P; Qin Y; Chen M; Feng Q; Pan J; Cheng Q; Liang F; Wen X; Wang Y; Shi Y; Cheng Y
Nanotheranostics; 2019; 3(1):41-53. PubMed ID: 30662822
[TBL] [Abstract][Full Text] [Related]
3. Magnetic nanoparticles for amalgamation of magnetic hyperthermia and chemotherapy: An approach towards enhanced attenuation of tumor.
Singh A; Jain S; Sahoo SK
Mater Sci Eng C Mater Biol Appl; 2020 May; 110():110695. PubMed ID: 32204010
[TBL] [Abstract][Full Text] [Related]
4. Human mesenchymal stem cell-derived iron oxide exosomes allow targeted ablation of tumor cells via magnetic hyperthermia.
Altanerova U; Babincova M; Babinec P; Benejova K; Jakubechova J; Altanerova V; Zduriencikova M; Repiska V; Altaner C
Int J Nanomedicine; 2017; 12():7923-7936. PubMed ID: 29138559
[TBL] [Abstract][Full Text] [Related]
5. Stem cell-based gene therapy activated using magnetic hyperthermia to enhance the treatment of cancer.
Yin PT; Shah S; Pasquale NJ; Garbuzenko OB; Minko T; Lee KB
Biomaterials; 2016 Mar; 81():46-57. PubMed ID: 26720500
[TBL] [Abstract][Full Text] [Related]
6. In vitro anti-cancer efficacy of multi-functionalized magnetite nanoparticles combining alternating magnetic hyperthermia in glioblastoma cancer cells.
Minaei SE; Khoei S; Khoee S; Vafashoar F; Mahabadi VP
Mater Sci Eng C Mater Biol Appl; 2019 Aug; 101():575-587. PubMed ID: 31029351
[TBL] [Abstract][Full Text] [Related]
7. Comparative evaluation of magnetic hyperthermia performance and biocompatibility of magnetite and novel Fe-doped hardystonite nanoparticles for potential bone cancer therapy.
Farzin A; Hassan S; Emadi R; Etesami SA; Ai J
Mater Sci Eng C Mater Biol Appl; 2019 May; 98():930-938. PubMed ID: 30813100
[TBL] [Abstract][Full Text] [Related]
8. Clinical hyperthermia of prostate cancer using magnetic nanoparticles: presentation of a new interstitial technique.
Johannsen M; Gneveckow U; Eckelt L; Feussner A; Waldöfner N; Scholz R; Deger S; Wust P; Loening SA; Jordan A
Int J Hyperthermia; 2005 Nov; 21(7):637-47. PubMed ID: 16304715
[TBL] [Abstract][Full Text] [Related]
9. Hyperthermia on mesenchymal stem cells (MSCs) can sensitize tumor cells to undergo cell death.
Park H; Cho JA; Kim SK; Kim JH; Lee SH
Int J Hyperthermia; 2008 Dec; 24(8):638-48. PubMed ID: 19065344
[TBL] [Abstract][Full Text] [Related]
10. Graphene Quantum Dots-Capped Magnetic Mesoporous Silica Nanoparticles as a Multifunctional Platform for Controlled Drug Delivery, Magnetic Hyperthermia, and Photothermal Therapy.
Yao X; Niu X; Ma K; Huang P; Grothe J; Kaskel S; Zhu Y
Small; 2017 Jan; 13(2):. PubMed ID: 27735129
[TBL] [Abstract][Full Text] [Related]
11. Magnetic Nanoparticles Labeled Mesenchymal Stem Cells: A Pragmatic Solution toward Targeted Cancer Theranostics.
Singh A; Jain S; Senapati S; Verma RS; Sahoo SK
Adv Healthc Mater; 2015 Oct; 4(14):2078-2089. PubMed ID: 26332511
[TBL] [Abstract][Full Text] [Related]
12. Preparation of carboplatin-Fe@C-loaded chitosan nanoparticles and study on hyperthermia combined with pharmacotherapy for liver cancer.
Li FR; Yan WH; Guo YH; Qi H; Zhou HX
Int J Hyperthermia; 2009 Aug; 25(5):383-91. PubMed ID: 19391033
[TBL] [Abstract][Full Text] [Related]
13. Magnetic fluid hyperthermia (MFH)reduces prostate cancer growth in the orthotopic Dunning R3327 rat model.
Johannsen M; Thiesen B; Jordan A; Taymoorian K; Gneveckow U; Waldöfner N; Scholz R; Koch M; Lein M; Jung K; Loening SA
Prostate; 2005 Aug; 64(3):283-92. PubMed ID: 15726645
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the effect of hyperthermia and electron radiation on prostate cancer stem cells.
Rajaee Z; Khoei S; Mahdavi SR; Ebrahimi M; Shirvalilou S; Mahdavian A
Radiat Environ Biophys; 2018 May; 57(2):133-142. PubMed ID: 29453555
[TBL] [Abstract][Full Text] [Related]
15. A prodrug-doped cellular Trojan Horse for the potential treatment of prostate cancer.
Levy O; Brennen WN; Han E; Rosen DM; Musabeyezu J; Safaee H; Ranganath S; Ngai J; Heinelt M; Milton Y; Wang H; Bhagchandani SH; Joshi N; Bhowmick N; Denmeade SR; Isaacs JT; Karp JM
Biomaterials; 2016 Jun; 91():140-150. PubMed ID: 27019026
[TBL] [Abstract][Full Text] [Related]
16. Effective elimination of cancer stem cells by magnetic hyperthermia.
Sadhukha T; Niu L; Wiedmann TS; Panyam J
Mol Pharm; 2013 Apr; 10(4):1432-41. PubMed ID: 23432410
[TBL] [Abstract][Full Text] [Related]
17. Biocompatibility and therapeutic evaluation of magnetic liposomes designed for self-controlled cancer hyperthermia and chemotherapy.
Gogoi M; Jaiswal MK; Sarma HD; Bahadur D; Banerjee R
Integr Biol (Camb); 2017 Jun; 9(6):555-565. PubMed ID: 28513646
[TBL] [Abstract][Full Text] [Related]
18. Secreted factors from metastatic prostate cancer cells stimulate mesenchymal stem cell transition to a pro-tumourigenic 'activated' state that enhances prostate cancer cell migration.
Ridge SM; Bhattacharyya D; Dervan E; Naicker SD; Burke AJ; Murphy JM; O'leary K; Greene J; Ryan AE; Sullivan FJ; Glynn SA
Int J Cancer; 2018 May; 142(10):2056-2067. PubMed ID: 29266277
[TBL] [Abstract][Full Text] [Related]
19. Heat-generating iron oxide nanocubes: subtle "destructurators" of the tumoral microenvironment.
Kolosnjaj-Tabi J; Di Corato R; Lartigue L; Marangon I; Guardia P; Silva AK; Luciani N; Clément O; Flaud P; Singh JV; Decuzzi P; Pellegrino T; Wilhelm C; Gazeau F
ACS Nano; 2014 May; 8(5):4268-83. PubMed ID: 24738788
[TBL] [Abstract][Full Text] [Related]
20. Enhanced efficacy of combination heat shock targeted polymer therapeutics with high intensity focused ultrasound.
Frazier N; Payne A; Dillon C; Subrahmanyam N; Ghandehari H
Nanomedicine; 2017 Apr; 13(3):1235-1243. PubMed ID: 27913213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
